Cargando…
HPV-based cervical cancer screening in Nicaragua: from testing to treatment
BACKGROUND: In Nicaragua, cervical cancer is the leading cause of cancer death among women. Human papillomavirus (HPV) testing, primarily using self-sampling, was introduced between 2014 and 2018 in three provinces. We analyzed data from the HPV screening program with the goal of describing key char...
Autores principales: | Holme, Francesca, Maldonado, Francisco, Martinez-Granera, Orlando B., Rodriguez, Jose Maria, Almendarez, Juan, Slavkovsky, Rose, Bansil, Pooja, Thomson, Kerry A., Jeronimo, Jose, de Sanjose, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161152/ https://www.ncbi.nlm.nih.gov/pubmed/32295562 http://dx.doi.org/10.1186/s12889-020-08601-z |
Ejemplares similares
-
Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project()
por: Holme, Francesca, et al.
Publicado: (2020) -
Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua
por: Campos, Nicole G, et al.
Publicado: (2017) -
Acceptability and safety of thermal ablation for the treatment of precancerous cervical lesions in Honduras
por: Sandoval, Manuel, et al.
Publicado: (2019) -
Recall Efforts Successfully Increase Follow-Up for Cervical Cancer Screening Among Women With Human Papillomavirus in Honduras
por: Thomson, Kerry A., et al.
Publicado: (2020) -
Health Outcomes at 1 Year After Thermal Ablation for Cervical Precancer Among Human Papillomavirus– and Visual Inspection With Acetic Acid–Positive Women in Honduras
por: Slavkovsky, Rose C., et al.
Publicado: (2020)